Yield Monitoring and Mapping

The monitoring and mapping of yield variations have captured the interest of many producers. The ability to monitor grain yield on-the-go and map the in-field variations for use in management decisions has come from a dream to near-reality. The paper and presentation will discuss the recent past, the present, and the near future of crop yield monitoring and mapping. An attempt to provide accurate, correct, and current information was made. However, some information may have changed and may be outdated. This paper is not an endorsement of the products or technologies

The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline

Do steroids improve neurologic symptoms in patients with metastatic brain tumors compared to no treatment? If steroids are given, what dose should be used? Comparisons include: (1) steroid therapy versus none. (2) comparison of different doses of steroid therapy. Target population These recommendations apply to adults diagnosed with brain metastases. Recommendations Steroid therapy versus no steroid therapy Asymptomatic brain metastases patients without mass effect Insufficient evidence exists to make a treatment recommendation for this clinical scenario. Brain metastases patients with mild symptoms related to mass effect Level 3 Corticosteroids are recommended to provide temporary symptomatic relief of symptoms related to increased intracranial pressure and edema secondary to brain metastases. It is recommended for patients who are symptomatic from metastatic disease to the brain that a starting dose of 4–8 mg/day of dexamethasone be considered. Brain metastases patients with moderate to severe symptoms related to mass effect Level 3 Corticosteroids are recommended to provide temporary symptomatic relief of symptoms related to increased intracranial pressure and edema secondary to brain metastases. If patients exhibit severe symptoms consistent with increased intracranial pressure, it is recommended that higher doses such as 16 mg/day or more be considered. Choice of Steroid Level 3 If corticosteroids are given, dexamethasone is the best drug choice given the available evidence. Duration of Corticosteroid Administration Level 3 Corticosteroids, if given, should be tapered slowly over a 2 week time period, or longer in symptomatic patients, based upon an individualized treatment regimen and a full understanding of the long-term sequelae of corticosteroid therapy. Given the very limited number of studies (two) which met the eligibility criteria for the systematic review, these are the only recommendations that can be offered based on this methodology. Please see “Discussion” and “Summary” section for additional details

Final Report of the 2016-17 Bylaws and Policy Development Committee

The AACP Bylaws direct the Bylaws and Policy Development Committee (BPDC) to ensure that resolutions, position papers and similar proposals to the House of Delegates that seek to establish Association policy or action are appropriate and ready for consideration by the House. The Committee is also charged with responsibility for receiving suggestions for alteration of the Association’s Articles of Incorporation or the Bylaws, preparing appropriate amendments in suitable wording that is consistent with the current Bylaws, and for presenting such proposals, together with the Committee’s recommendations, to the House of Delegates for consideration. This report contains eight adopted statements/ resolutions of policy, seven referred statements/resolutions of policy, adopted amendments to the AACP bylaws, and adopted modifications to AACP cumulative policies